Europe Pain Management Drugs Market Forecast 2019-2027

Europe Pain Management Drugs Market Forecast 2019-2027

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. OPIOIDS MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DRUG CLASS
3.2.2. CANCER PAIN INDICATION IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. GROWTH IN THE INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
4.2.2. THE RISE IN AWARENESS REGARDING THE SIDE-EFFECTS OF PAIN MEDICATION
4.2.3. RISE IN GERIATRIC POPULATION
4.3. MARKET RESTRAINTS
4.3.1. ACCESSIBILITY OF ALTERNATIVE THERAPIES
4.3.2. INCREASE IN DRUG MISTREATMENT
4.4. MARKET OPPORTUNITIES
4.4.1. TECHNOLOGICAL ADVANCEMENT
4.4.2. GROWTH POTENTIAL IN UNTAPPED ECONOMIES
4.5. MARKET CHALLENGES
4.5.1. PATENT EXPIRATION
5. MARKET BY DRUG CLASS
5.1. NSAIDS
5.2. ANESTHETICS
5.3. ANTICONVULSANTS
5.4. ANTI-MIGRAINE AGENTS
5.5. ANTIDEPRESSANTS
5.6. OPIOIDS
5.7. NON-NARCOTIC ANALGESICS
6. MARKET BY INDICATION
6.1. ARTHRITIC PAIN
6.2. NEUROPATHIC PAIN
6.3. CANCER PAIN
6.4. CHRONIC BACK PAIN
6.5. POST-OPERATIVE PAIN
6.6. MIGRAINE
6.7. FIBROMYALGIA
7. KEY ANALYTICS
7.1. PORTER'S FIVE FORCE MODEL
7.1.1. THREAT OF NEW ENTRANTS
7.1.2. THREAT OF SUBSTITUTE
7.1.3. BARGAINING POWER OF SUPPLIERS
7.1.4. BARGAINING POWER OF BUYERS
7.1.5. THREAT OF COMPETITIVE RIVALRY
7.2. REGULATORY FRAMEWORK
7.3. OPPORTUNITY MATRIX
7.4. VALUE CHAIN ANALYSIS
7.5. VENDOR LANDSCAPE
8. GEOGRAPHICAL ANALYSIS
8.1. EUROPE
8.1.1. GERMANY
8.1.2. FRANCE
8.1.3. THE UNITED KINGDOM
8.1.4. ITALY
8.1.5. SPAIN
8.1.6. REST OF EUROPE
9. COMPETITIVE LANDSCAPE
9.1. MARKET SHARE ANALYSIS
9.2. COMPANY PROFILES
9.2.1. ABBOTT LABORATORIES
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT PORTFOLIO
9.2.1.3. SCOT ANALYSIS
9.2.1.4. STRATEGIC INITIATIVES
9.2.2. ACURA PHARMACEUTICALS, INC.
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT PORTFOLIO
9.2.2.3. STRATEGIC INITIATIVES
9.2.3. CIPHER PHARMACEUTICALS INC.
9.2.3.1. COMPANY PROFILES
9.2.3.2. PRODUCT PORTFOLIO
9.2.3.3. STRATEGIC INITIATIVES
9.2.4. DAIICHI SANKYO, INC.
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT PORTFOLIO
9.2.4.3. STRATEGIC INITIATIVES
9.2.5. EGALET CORP.
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT PORTFOLIO
9.2.5.3. STRATEGIC INITIATIVES
9.2.6. ELI LILLY AND COMPANY
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT PORTFOLIO
9.2.6.3. SCOT ANALYSIS
9.2.6.4. STRATEGIC INITIATIVES
9.2.7. GLAXOSMITHKLINE
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT PORTFOLIO
9.2.7.3. SCOT ANALYSIS
9.2.7.4. STRATEGIC INITIATIVES
9.2.8. HIKMA PHARMACEUTICALS PLC
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT PORTFOLIO
9.2.8.3. STRATEGIC INITIATIVES
9.2.9. JOHNSON & JOHNSON
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT PORTFOLIO
9.2.9.3. SCOT ANALYSIS
9.2.9.4. STRATEGIC INITIATIVES
9.2.10. LUPIN LTD.
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT PORTFOLIO
9.2.10.3. STRATEGIC INITIATIVES
9.2.11. PFIZER, INC.
9.2.11.1. COMPANY PROFILES
9.2.11.2. PRODUCT PORTFOLIO
9.2.11.3. SCOT ANALYSIS
9.2.11.4. STRATEGIC INITIATIVES
9.2.12. PURDUE PHARMA L.P.
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCT PORTFOLIO
9.2.12.3. STRATEGIC INITIATIVES
9.2.13. MERCK & CO., INC.
9.2.13.1. COMPANY PROFILES
9.2.13.2. PRODUCT PORTFOLIO
9.2.13.3. SCOT ANALYSIS
9.2.13.4. STRATEGIC INITIATIVES
9.2.14. NOVARTIS
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCT PORTFOLIO
9.2.14.3. SCOT ANALYSIS
9.2.14.4. STRATEGIC INITIATIVES
9.2.15. INSYS THERAPEUTICS, INC.
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCT PORTFOLIO
9.2.15.3. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 EUROPE PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
TABLE 2 EUROPE PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 3 EUROPE NSAIDS MARKET 2019-2027 ($ MILLION)
TABLE 4 EUROPE ANESTHETICS MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE ANTICONVULSANTS MARKET 2019-2027 ($ MILLION)
TABLE 6 EUROPE ANTI-MIGRAINE AGENTS MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE ANTIDEPRESSANTS MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE OPIOIDS MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE NON-NARCOTIC ANALGESICS MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE 11 EUROPE ARTHRITIC PAIN MARKET 2019-2027 ($ MILLION)
TABLE 12 EUROPE NEUROPATHIC PAIN MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE CANCER PAIN MARKET 2019-2027 ($ MILLION)
TABLE 14 EUROPE CHRONIC BACK PAIN MARKET 2019-2027 ($ MILLION)
TABLE 15 EUROPE POST-OPERATIVE PAIN MARKET 2019-2027 ($ MILLION)
TABLE 16 EUROPE MIGRAINE MARKET 2019-2027 ($ MILLION)
TABLE 17 EUROPE FIBROMYALGIA MARKET 2019-2027 ($ MILLION)
TABLE 18 EUROPE PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
TABLE 19 EUROPE PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 20 GERMANY PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 21 GERMANY PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE 22 FRANCE PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 23 FRANCE PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE 24 THE UNITED KINGDOM PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 25 THE UNITED KINGDOM PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE 26 ITALY PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 27 ITALY PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE 28 SPAIN PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 29 SPAIN PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

FIGURES LIST
FIGURE 1 EUROPE PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 2 EUROPE PAIN MANAGEMENT DRUGS MARKET SHARE BY DRUG CLASS 2018 & 2027 (%)
FIGURE 3 EUROPE PAIN MANAGEMENT DRUGS MARKET BY NSAIDS 2019-2027 ($ MILLION)
FIGURE 4 EUROPE PAIN MANAGEMENT DRUGS MARKET BY ANESTHETICS 2019-2027 ($ MILLION)
FIGURE 5 EUROPE PAIN MANAGEMENT DRUGS MARKET BY ANTICONVULSANTS 2019-2027 ($ MILLION)
FIGURE 6 EUROPE PAIN MANAGEMENT DRUGS MARKET BY ANTI-MIGRAINE AGENTS 2019-2027 ($ MILLION)
FIGURE 7 EUROPE PAIN MANAGEMENT DRUGS MARKET BY ANTIDEPRESSANTS 2019-2027 ($ MILLION)
FIGURE 8 EUROPE PAIN MANAGEMENT DRUGS MARKET BY OPIOIDS 2019-2027 ($ MILLION)
FIGURE 9 EUROPE PAIN MANAGEMENT DRUGS MARKET BY NON-NARCOTIC ANALGESICS 2019-2027 ($ MILLION)
FIGURE 10 EUROPE PAIN MANAGEMENT DRUGS MARKET SHARE BY INDICATION 2018 & 2027 (%)
FIGURE 11 EUROPE PAIN MANAGEMENT DRUGS MARKET BY ARTHRITIC PAIN 2019-2027 ($ MILLION)
FIGURE 12 EUROPE PAIN MANAGEMENT DRUGS MARKET BY NEUROPATHIC PAIN 2019-2027 ($ MILLION)
FIGURE 13 EUROPE PAIN MANAGEMENT DRUGS MARKET BY CANCER PAIN 2019-2027 ($ MILLION)
FIGURE 14 EUROPE PAIN MANAGEMENT DRUGS MARKET BY CHRONIC BACK PAIN 2019-2027 ($ MILLION)
FIGURE 15 EUROPE PAIN MANAGEMENT DRUGS MARKET BY POST-OPERATIVE PAIN 2019-2027 ($ MILLION)
FIGURE 16 EUROPE PAIN MANAGEMENT DRUGS MARKET BY MIGRAINE 2019-2027 ($ MILLION)
FIGURE 17 EUROPE PAIN MANAGEMENT DRUGS MARKET BY FIBROMYALGIA 2019-2027 ($ MILLION)
FIGURE 18 PORTER'S FIVE FORCE MODEL
FIGURE 19 EUROPE PAIN MANAGEMENT DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 20 GERMANY PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 21 FRANCE PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 22 THE UNITED KINGDOM PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 23 ITALY PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 24 SPAIN PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 25 REST OF EUROPE PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 26 PAIN MANAGEMENT MARKET SHARE ANALYSIS 2017 (%)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs